History 

2024

2024.10

- Renewal of Medical Device Manufacturing and Quality Management Standards Certificate (GMP) KTC-ABBA-21568
- Supervised by MFDS and Korea Testing Certification Institute (KTC)

2024.09

- Submission of Designated Audit Application to Financial Supervisory Service External Audit Report System

2024.08

- Lead Underwriting Agreement for KOSDAQ Listing with Hana Securities, Convertible Bond Issuance (Pre-IPO Investment)

2024.06

- RCPS Issuance: 1,748,810 Preferred Shares at KRW 6,290 per share, Totaling KRW 11,000,014,900 

2024.04

 - SME Certification 0010-2024-317952, Supervised by the Ministry of SMEs and Startups

2024.03

- China Trademark Patent Registration for REVOSTEM (乐博思黛) No. 74344887

- Morocco Product Certification for Hilthera 4.0: 50624/2023/4381-2024/DM/DPS/DMP/18

2023~2020

2023.12

- $3 Million Export Tower Award – Korea International Trade Association

- Gyeonggi Province Export Achievement Award – Certificate No. 15121, supervised by the Ministry of SMEs and Startups

- Domestic ReWave Trademark Patent Registration – No. 40-2121470-0000

2023.11

- Official Distributor Status Granted to Shanghai REV-MED Co., Ltd. (Legal Entity Status Acquired in China)

- Inno-Biz Certification (Technology-Innovative Small Business) – Certificate No. R170605-01132, supervised by the Ministry of SMEs and Startups

- Tricell PRP Morocco Product Certification – Certification No. 50624/2023/4381-2024/DM/DPS/DMP/18

- Main-Biz Certification (Management-Innovative Small Business) – Certificate No. 230601-03281, supervised by the Ministry of SMEs and Startups

2023.08
- Establishment of Shanghai REV-MED Co., Ltd.

2022.10

- Issuance of Convertible Bonds (Pre-IPO Investment Secured)

- Veterinary Medical Device Manufacturing License Acquired

- Korea MFDS Approval (Class III): TriCell PRP UNI

2021.07

- Korea MFDS Approval (Class III): Blood Processing Device (NovaStem BC)

- Korea MFDS Approval (Class III): Bone Marrow Processing Device (NovaStem BMAC)

2020.11

- Inno-Biz Certification (Technology-Innovative Small Business)

- Korea MFDS Approval (Class III): Fat Separation Device (DUOCELL SVF KIT)

2020.04

- ISO 13485: 2018 Certification Acquired

- Hilthera 4.0 CE Certification Acquired

2019~2017

2019.01

- Taiwan Medical Device Certification: Hilthera 4.0

2018.12

- Development and Commercialization of Bone Marrow Processing Device

2018.11

- World-Class Product Certification

2018.09

- Development of Large-Capacity 50ml Autologous Bone Marrow Processing Device

2018.03

- Opening of REV-MED Stem Cell Research Institute

2017.05

- Opening of Laser Division

2017.03

- Japan PMDA Approval: Blood Processing Device (Class III, TriCell PRP)  

2016~2009

2016.08

- Health Technology (NET) Certification 

2016.06

- China CFDA (NMPA) Approval: Blood Processing Device (Class III, TriCell PRP) 

2016.03

- Korean MFDS Approval: Bone Marrow Processing Device (Class III, TriCell BMC) 

2015.12

- Establishment of REV-MED International GmbH in Germany (Joint Venture) 

2015.01~2015.12

- Blood Processing Device Development (Gyeonggi Science and Technology Promotion Agency)

2014.07~2015.07

- Development of Autologous Bone Marrow-Derived Stem Cell and Nucleated Cell Concentration Kit 

2013.10

- Opening of Corporate Research Institute 

2012.10

- ISO 13485: 2012 Certification Acquired

- TriCell PRP CE Certification Acquired

2012.07

- Korean MFDS Approval: Blood Processing Device (Class III, TriCell PRP) 

2009.01

- Establishment of REV-MED Corporation